| Literature DB >> 20111730 |
Elisa Visani1, Ludovico Minati, Laura Canafoglia, Isabella Gilioli, Lucia Salvatoni, Giulia Varotto, Patrik Fazio, Domenico Aquino, Maria Grazia Bruzzone, Silvana Franceschetti, Ferruccio Panzica.
Abstract
We performed simultaneous acquisition of EEG-fMRI in seven patients with Unverricht-Lundborg disease (ULD) and in six healthy controls using self-paced finger extension as a motor task. The event-related desynchronization/synchronization (ERD/ERS) analysis showed a greater and more diffuse alpha desynchronization in central regions and a strongly reduced post-movement beta-ERS in patients compared with controls, suggesting a significant dysfunction of the mechanisms regulating active movement and movement end. The event-related hemodynamic response obtained from fMRI showed delayed BOLD peak latency in the contralateral primary motor area suggesting a less efficient activity of the neuronal populations driving fine movements, which are specifically impaired in ULD.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20111730 PMCID: PMC2810451 DOI: 10.1155/2010/164278
Source DB: PubMed Journal: Comput Intell Neurosci
Patient data.
| Subject, Age [yrs], Sex | Disease duration [yrs] | AED | Simplified myoclonus rating |
|---|---|---|---|
| 1, 22, f | 12 | VPA, TPM, CLZ | 2 |
| 2, 26, f | 16 | VPA, CZP | 2 |
| 3, 36, m | 22 | VPA, LVT, PB | 2 |
| 4, 25, m | 14 | VPA, CZP, piracetam | 3 |
| 5, 49, m | 34 | VPA, TPM | 2 |
| 6, 22, f | 11 | VPA, LVT, TPM | 2 |
| 7, 24, f | 12 | VPA | 3 |
AED: antiepileptic drugs; VPA: valproate; TPM: topiramate; CLZ: clobazam; CZP: clonazepam LVT: levetiracetam; PB: phenobarbital. Simplified myoclonous rating [5]: 2: mild myoclonous, interference with fine movements and/or speech, no interference with walking; 3: moderate myoclonous, patient still able to walk without support.
Figure 1Color maps showing the grand average of α-ERD in control subjects (a) and in patients (b). Color scale: maximum ERD and ERS are coded in blue and red. The lower panels show the grand average of α-ERD time series recorded from contralateral (c) and ipsilateral (d) central derivations in patients and controls.
Statistical analysis of ERD/ERS values assessed in subsequent epochs.
| Alpha ERD | F4 | C4 | P4 | F3 | C3 | P3 | Fz | Cz | Pz |
|---|---|---|---|---|---|---|---|---|---|
|
| — | 0.015 | — | — | — | — | — | 0.032 | — |
|
| — | 0.010 | — | — | — | 0.042 | — | — | — |
|
| — | 0.003 | — | — | — | — | — | 0.003 | — |
|
| 0.045 | 0.010 | — | — | 0.015 | 0.004 | 0.007 | 0.003 | 0.032 |
|
| — | — | — | — | — | — | — | 0.007 | — |
|
| |||||||||
| Beta ERD/ERS* | F4 | C4 | P4 | F3 | C3 | P3 | Fz | Cz | Pz |
|
| |||||||||
|
| — | — | — | — | — | — | — | — | — |
|
| — | — | — | — | — | — | — | — | — |
|
| — | — | — | — | — | — | — | — | — |
|
| 0.032 | — | 0.007 | — | 0.032 | — | 0.015 | — | — |
|
| — | 0.032 | 0.022 | — | 0.012 | — | — | 0.010 | — |
Results of U-Mann Whitney test between patients and controls group. —= not significant. *t1- t3 correspond to beta ERD and t4-t5 to beta ERS.
Figure 2Color maps showing the grand average of β-ERD/ERS in control subjects (a) and patients (b). Color scale: maximum ERD and ERS are coded in blue and red. The lower panel (c) shows the grand average of β-ERD/ERS time series recorded from the contralateral central derivation in patients and controls.
Figure 3Time-courses of the hemodynamic response for controls (blue) and patients (red).